Business UpdateMay 27, 2026, 07:02 AM
Telix CEO to Present at William Blair & Jefferies Conferences
AI Summary
Telix Pharmaceuticals announced that its Managing Director and Group CEO, Dr. Christian Behrenbruch, will participate in two investor conferences in early June 2026. He is scheduled to present at the William Blair 46th Annual Growth Stock Conference on June 2 and the Jefferies Global Healthcare Conference on June 3. Both presentations will be webcast live for investors.
Key Highlights
- Telix Pharmaceuticals' Managing Director and Group CEO, Dr. Christian Behrenbruch, will participate in two upcoming investor conferences.
- He will present at the William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 8:00 a.m. CDT.
- He will also present at the Jefferies Global Healthcare Conference on June 3, 2026, at 11:40 a.m. EDT.
- Both conference sessions will be webcast live and accessible through Telix's Investor Relations website.
Price Impact
More from TLX